Maintenance of Brain Monoamine Oxidase B Inhibition in Smokers After Overnight Cigarette Abstinence
- 1 November 2000
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 157 (11) , 1864-1866
- https://doi.org/10.1176/appi.ajp.157.11.1864
Abstract
OBJECTIVE: The authors’ goal was to replicate a previous finding that smokers have lower brain monoamine oxidase B (MAO-B) levels than comparison nonsmoking subjects and to determine if levels recover after overnight cigarette abstinence. METHOD: Brain MAO-B levels were measured by means of positron emission tomography in six smokers who were scanned twice: 11.3 hours (baseline) and 10 minutes after smoking one cigarette. RESULTS: Average MAO-B levels in smokers in the present study were similar to those found in the previous study and averaged 39% (SD=17) lower than those found in a comparison group of nonsmokers. Brain MAO-B levels did not differ between baseline levels and 10 minutes after smoking. CONCLUSIONS: This study reinforces the need to investigate whether MAO-B inhibition may account for some of the behavioral and epidemiological features of smoking.Keywords
This publication has 8 references indexed in Scilit:
- Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco LeavesChemical Research in Toxicology, 1999
- Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokersNicotine & Tobacco Research, 1999
- Schizophrenia, Monoamine Oxidase Activity, and Cigarette SmokingNeuropsychopharmacology, 1999
- Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human SubjectsNeurobiology of Aging, 1997
- Inhibition of monoamine oxidase B in the brains of smokersNature, 1996
- Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's diseaseNeurology, 1993
- Comparison of tests used to distinguish smokers from nonsmokers.American Journal of Public Health, 1987
- How a cigarette is smoked determines blood nicotine levelsClinical Pharmacology & Therapeutics, 1983